Amedisys (STU:ADY) LT-Debt-to-Total-Asset : 0.20 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Amedisys LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Amedisys's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.20.

Amedisys's long-term debt to total assets ratio declined from Mar. 2023 (0.22) to Mar. 2024 (0.20). It may suggest that Amedisys is progressively becoming less dependent on debt to grow their business.

Amedisys LT-Debt-to-Total-Asset Historical Data

The historical data trend for Amedisys's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amedisys LT-Debt-to-Total-Asset Chart

Amedisys Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.23

0.17

0.27

0.25

0.21

Amedisys Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.22	0.22	0.21	0.21	0.20

Amedisys LT-Debt-to-Total-Asset Calculation

Amedisys's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	389.37	/	1889.176
	=	0.21

Amedisys's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	384.836	/	1922.681
	=	0.20

Amedisys (STU:ADY) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Amedisys LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Amedisys's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Amedisys (STU:ADY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Amedisys Inc (STU:ADY) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

AMED:USA ADY:Germany

Address

3854 American Way, Suite A, Baton Rouge, LA, USA, 70816

Website

https://www.amedisys.com

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Amedisys (STU:ADY) Headlines

No Headlines